Related Experiment Video
Updated: Jul 22, 2026

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models
Published on: June 30, 2021
Rapid At-Line AAVX Affinity HPLC: Enabling Process Analytical Technology for Bioprocess Development of
Jakob Heckel1, Timo Bohlig2, Lea Bonnington1
1Pharma Technical Development Analytics, Roche Diagnostics GmbH, Penzberg, Germany.
Developing new analytical tools is crucial for efficient recombinant adeno-associated virus (rAAV) production. An AAVX affinity HPLC method provides fast capsid titer and filled capsid percentages for improved process monitoring and control in gene therapies.
Area of Science:
- Biotechnology and Gene Therapy
- Process Analytical Technology (PAT)
- Analytical Chemistry
Background:
- Recombinant adeno-associated virus (rAAV) vectors show therapeutic promise but face production challenges.
- Process Analytical Technology (PAT) can enhance rAAV production, but lacks suitable analytical tools.
- Existing methods struggle with consistent and efficient rAAV production.
Purpose of the Study:
- To evaluate a novel AAVX affinity-based high-performance liquid chromatography (HPLC) method as an at-line PAT tool.
- To determine capsid titer and percentage of filled capsids during rAAV production.
- To demonstrate the method's utility for improved process monitoring and control.
Main Methods:
- Development and application of an AAVX affinity-based HPLC method.
- At-line analysis of rAAV samples during upstream and downstream processing (DSP).
- Quantification of capsid titer and filled capsid percentages.
Main Results:
- The AAVX HPLC method provides fast and robust determination of capsid titer and filled capsid percentages.
- The method effectively analyzes challenging samples from fermentation and DSP stages.
- Demonstrated improved process monitoring and control capabilities.
Conclusions:
- The developed AAVX HPLC method serves as a valuable at-line PAT tool for rAAV production.
- The method's versatility across different rAAV serotypes and payloads supports streamlined process development.
- This contributes to high-quality, cost-efficient production of rAAV-based gene therapies.
More Related Videos
10:31Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System
Published on: January 13, 2022
09:12Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors
Published on: April 5, 2024